Related Experiment Video
Updated: Aug 17, 2026

Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Cholecystokinin interacts with prefeeding to impair runway performance
Abstract:
Previous experiments demonstrated the ineffectiveness of the C-terminal octapeptide of cholecystokinin (CCK-8) for impairing runway performance by food-deprived rats. These results were consistent with the proposal that CCK-8 does not reduce food intake by inhibiting appetitive motivation but instead acts late in the meal to prematurely trigger satiety. For further evaluation of this hypothesis, the effect of CCK-8 on runway performance was assessed after 21 h food-deprived rats consumed a partial meal of 30% sucrose. Injection of 1.0 micrograms/kg CCK-8 after rats were allowed 3 min (6.2 ml consumed) or 5 min (9.7 ml) access to 30% sucrose produced significant reductions in running speed of 43% and 70%, respectively. After 5 min prefeeding, 0.25 and 0.50 micrograms/kg CCK-8 also produced significant decreases in speed of 20% and 59%, respectively. By contrast, CCK-8 had little or no effect without prefeeding. Doses of 0.25 and 0.50 micrograms/kg failed to affect running speed on these tests and 1.0 micrograms/kg produced a small (7%) though significant decrease. These results suggest that inhibition of feeding motivation after CCK-8 administration develops during the course of the meal through interaction with signals generated by the ingestion of food.
Related Concept Videos
Hormonal Regulation
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Depolarizing Blockers: Pharmocokinetics
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Cholecystitis

